CoChat
Sign Up
Cited by 12

The DOI matches its Crossref record.

Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?

Duran, Goretti, Cruz, Raquel, Simoes, Ana Rita, Barros, Francisco, Giráldez, José María, Bernárdez, Beatriz, Anido, Urbano, Candamio, Sonia, López-López, Rafael, Carracedo, Ángel, Lamas, María Jesús·2020·Journal of Chemotherapy
DOI 10.1080/1120009x.2020.1764281
Open this paper in CoChat — free account

Abstract

We studied the predictive value for response and toxicity of functional polymorphisms in genes involved in the oxaliplatin/fluorouracil pathway in colorectal cancer patients. One hundred and twenty-seven (127) patients were treated with curative intended surgery followed by adjuvant chemotherapy with FOLFOX (fluorouracil, leucovorin and oxaliplatin) regimen. The median age was 65.53 (27-80) years (66.9% male, 59.1% rectum). The median follow-up was 8.5 years (IQR, 4.1-9.4). At the end of follow-up, 59 patients (46.5%) had relapsed or died in the whole study population. We did find that XRCC1GG genotype is associated with a higher risk of developing haematologic toxicity. Furthermore, we report a significant association of the TS 3'UTR 6 bp/6 bp polymorphism and the XRCC1 rs25487 with a higher risk of developing anaemia and diarrhoea, respectively. On the other hand, none of the studied polymorphisms showed clinically relevant association with disease-free survival and overall survival or early failure to adjuvant FOLFOX therapy.

Overview

Integrity signals

Registry

Crossref · 10.1080/1120009x.2020.1764281

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 45

  1. 10.1136/gutjnl-2015-310912 · DOI
  2. 10.1200/JCO.2008.20.6771 · DOI
  3. 10.1200/JCO.2006.08.2974 · DOI
  4. 10.1016/S1470-2045(14)70377-8 · DOI
  5. 10.3389/fphar.2017.00736 · DOI
  6. 10.1016/j.drup.2015.05.003 · DOI
  7. Aiello M, 2011, Mol Med Rep, 4, 203
  8. 10.1093/annonc/mdw235 · DOI · Paper page
  9. 10.2217/pgs-2016-0191 · DOI
  10. 10.1038/clpt.2013.214 · DOI
  11. 10.7150/jca.8594 · DOI
  12. 10.3748/wjg.v20.i29.9775 · DOI
  13. 10.1016/j.jmoldx.2016.11.001 · DOI
  14. 10.2217/pgs.10.51 · DOI
  15. 10.1200/JCO.2013.50.7442 · DOI
  16. 10.1097/SLA.0b013e318142d918 · DOI
  17. Liu W, 2015, Zhonghua Wei Chang Wai Ke Za Zhi, 18, 1098
  18. 10.1002/jso.21404 · DOI
  19. 10.1111/j.1743-7563.2010.01275.x · DOI
  20. 10.1016/j.amjsurg.2005.03.012 · DOI
  21. Taflin H, 2011, Anticancer Res, 31, 3057
  22. 10.1158/1535-7163.MCT-13-1109 · DOI
  23. 10.1007/BF03256419 · DOI
  24. 10.1007/s00280-013-2075-3 · DOI
  25. 10.1200/JCO.2004.05.064 · DOI
  26. 10.1177/147323001003800313 · DOI
  27. 10.1158/1535-7163.MCT-06-0327 · DOI
  28. 10.1016/S1470-2045(18)30686-7 · DOI
  29. 10.1200/JCO.2009.25.2106 · DOI
  30. 10.1038/srep06828 · DOI
  31. 10.1097/FPC.0b013e32835ee8e1 · DOI
  32. 10.1038/sj.bjc.6605052 · DOI
  33. 10.1158/1078-0432.CCR-11-0304 · DOI
  34. 10.1200/JCO.2008.21.6283 · DOI
  35. 10.1517/17425255.2015.1027684 · DOI
  36. 10.1038/bjc.2013.262 · DOI
  37. 10.1200/JCO.2013.51.1857 · DOI
  38. 10.1016/j.clcc.2014.11.002 · DOI · Paper page
  39. 10.1111/j.1349-7006.2009.01418.x · DOI
  40. 10.1007/s00280-013-2145-6 · DOI
  41. 10.1158/1078-0432.CCR-05-2076 · DOI
  42. 10.1007/s00280-013-2194-x · DOI
  43. 10.1097/CAD.0000000000000002 · DOI
  44. 10.1016/j.lungcan.2008.02.019 · DOI
  45. 10.3892/mmr.2013.1435 · DOI

Cited by

Sorted by citations

See all 12

Metadata

Authors
Duran, G., Cruz, R., Simoes, A. R., Barros, F., Giráldez, J. M., Bernárdez, B., Anido, U., Candamio, S., López-López, R., Carracedo, Á., & Lamas, M. J.
Venue
Journal of Chemotherapy
Publisher
Informa UK Limited
Published
2020-05-22
Volume
32
Issue
6
Pages
310-322
ISSN
  • 1120-009X
  • 1973-9478
DOI
10.1080/1120009x.2020.1764281
Cited by
12
References
0
Language
en
Update notices
correction (2020-07-10)
Funders
  • Ministerio de Ciencia e Innovación
  • Fundación Ramón Areces,
  • Fundación Barrie de la Maza

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics? https://app.cochat.ai/papers/10.1080/1120009x.2020.1764281
The paper
Duran, G., Cruz, R., Simoes, A. R., Barros, F., Giráldez, J. M., Bernárdez, B., Anido, U., Candamio, S., López-López, R., Carracedo, Á., & Lamas, M. J. (2020). Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics? Journal of Chemotherapy. https://doi.org/10.1080/1120009x.2020.1764281